Worldwide Contacts

If you don't find your country in the list, see our worldwide contacts in:

Africa | Asia/Pacific | Europe | Latin America & Caribbean | Middle East | North America

News  
 

News
Press CentrePress Center
SAS in the NewsSAS in the News
Accessing & ManipulatingThe Economic TimesAccessing & ManipulatingBusiness India
Accessing & ManipulatingBusiness Today
Accessing & ManipulatingBusiness Standard
Accessing & ManipulatingThe Financial Express
The Times Of IndiaThe Times Of India
The HinduThe Hindu
The HinduHindu Business Line
Accessing & ManipulatingDataquest
Hindu Business LineIndia Infoline
Accessing & ManipulatingCIOL
Accessing & Manipulating
My Iris
Accessing & Manipulating
Sify News
Accessing & ManipulatingDomain-B
Accessing & ManipulatingCXOtoday
Accessing & ManipulatingExpress Computer
Accessing & ManipulatingArchives
Subscribe to sas.com  sas com

SAS eyes US$100mn Indian clinical research market - April 13, 2005

SAS announced the launch of SAS drug development 3.0.

Based on the capabilities of the SAS 9 intelligence platform, SAS drug development provides a centralized repository that allows life sciences firms to analyze their clinical research for regulatory submission and explore new market opportunities, product line extensions and safety issues, all within a controlled and secure collaborative framework designed for life sciences research industries.

SAS drug development has been designed to meet federal regulations such as 21 CFR Part 11, good industry practices and sound business practices.

Commenting on the launch, Sudipta K Sen, MD & CEO, SAS India Pvt. Ltd. said "Pharmaceutical companies in India are gearing to find out innovative ways to effectively manage, analyze, and explore massive amounts of complex data, and still minimize their time to market. SAS Drug Development provides an integrated system for managing, analyzing, reporting and reviewing clinical research information. The solution also allows companies to increase revenue potential, enhance the productivity of the clinical research team and improve clinical program investment decisions - all in an environment that facilitates regulatory compliance."

NEWS

Take Action
Phone 022-5634-9400 Ext.237
Email rajiv.kumar@sas.com

India Infoline
 
 

SAS eyes US $100MN Indian Clinical Research Market
April 13,  2005


SAS CEO J. Goodnight to visit India
Nov 22,  2004

Wipro & SAS to develop biz intelligence solutions
Nov 19,  2004

SAS Launches Financial Intelligence Solution
Oct 21,  2004

Sudipta Sen is new CEO & MD at SAS India
Oct 10,  2004

SAS India ties up with Datamatics Tech
Sept 15,  2004

SAS launches powerful analytics-driven product
Sept 29, 2004

SAS bags Business Intelligence Vendor 2004 Award
August 17, 2004

SAS(r) maximizes profitability for Retailers
June , 2004

SAS unveils SAS 9 platform in India
May 17, 2004

SAS unveils SAS 9 platform in India
March 31, 2004

SAS Asia Pacific registers double-digit growth in '03
March 08, 2004

Back to Top